Disc Medicine, Inc.
NASDAQ:IRONBiotechnology
Healthcare
$76.11 -0.03%
-$0.02 today
- Market cap
- $2.92B
- Beta
- 2.10
- P/E (TTM)
- -11.2
- EPS (TTM)
- -$6.28
52W Low $40.00High $99.50
Volume 0.65M
Average 0.47M
Income Statement
Follow revenue through to earnings.
Revenue
$0.00
FY 2025 · Annual
Operating Income
-$236.02M
FY 2025 · Annual
Net Income
-$212.18M
FY 2025 · Annual
Income Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Gross Margin | — | — | — | — | — |
| Research & Development | 25.17M | 33.44M | 69.26M | 96.67M | 170.64M |
| Selling, General & Admin | 5.76M | 14.04M | 21.86M | 33.05M | 65.38M |
| Operating Expenses | 30.93M | 47.48M | 91.13M | 129.72M | 236.02M |
| Depreciation & Amortization | 32K | 89K | 100K | 156K | 281K |
| EBITDA | (33.78M) | (46.74M) | (76.23M) | (108.27M) | (207.94M) |
| EBITDA Margin | — | — | — | — | — |
| Operating Income | (30.93M) | (47.48M) | (91.13M) | (129.72M) | (236.02M) |
| Operating Margin | — | — | — | — | — |
| Interest Income | 14K | 709K | 14.8M | 21.29M | 27.76M |
| Interest Expense | 2.16M | 0 | 0 | 572K | 3.61M |
| Other Income / Expenses | (5.04M) | 648K | 14.8M | 20.72M | 24.2M |
| Income Before Tax | (35.97M) | (46.83M) | (76.33M) | (109M) | (211.82M) |
| Pre-Tax Margin | — | — | — | — | — |
| Income Tax Expense | 0 | 0 | 99K | 355K | 361K |
| Net Income | (35.97M) | (46.83M) | (76.43M) | (109.36M) | (212.18M) |
| Net Margin | — | — | — | — | — |
| EPS (Basic) | (44.88) | (45.05) | (3.42) | (3.96) | (6.01) |
| EPS (Diluted) | (44.88) | (45.05) | (3.42) | (3.96) | (6.01) |
| 801.47K | 1.04M | 22.32M | 27.61M | 35.3M | |
| 801.47K | 1.04M | 22.32M | 27.61M | 35.3M |
IRON Earnings Waterfall · TTM
NASDAQ:IRON · Revenue to Net Income
Key Ratios
EPS$-6.36
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-11.1
P/S Ratio0.0
Analysis
$0 of revenue converted into -$243.1M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-6.36, tying the income statement back to per-share earnings.
Competitors
Peer companies in the same sector
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 12, 2026 | |
| 10-Q | Quarterly report | Nov 5, 2026 | |
| 8-K | Current report | Nov 5, 2026 | |
| 424B5 | 424B5 filing | Nov 5, 2026 | |
| SC 13D/A | SC 13D/A filing | Oct 26, 2026 |
How much revenue does IRON generate?
Disc Medicine, Inc. (IRON) reported $0.00 of revenue in fiscal 2025.
Is IRON profitable?
Disc Medicine, Inc. (IRON) reported -$212.18M of net income.
Continue the stock analysis
Jump to another research area for this company.